Azithromycin/ceftriaxone/remdesivirBradycardia and lack of efficacy following off-label use: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1896卷 / 1期

关键词：

D O I：

10.1007/s40278-022-10870-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：79 / 79

相关论文

共 50 条

[1] FavipiravirHyperuricaemia and lack of efficacy following off-label use: 2 case reports
[J]. Reactions Weekly, 2022, 1903 (1) : 182 - 182
[2] Multiple drugsMucormycosis and lack of efficacy following off-label use: 2 case reports
[J]. Reactions Weekly, 2022, 1935 (1) : 314 - 314
[3] Azithromycin/hydroxychloroquine/nitazoxanideDiarrhoea and lack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2023, 1940 (1) : 104 - 104
[4] AntineoplasticsLymphopenia following off-label use and lack of efficacy: 4 case reports
[J]. Reactions Weekly, 2021, 1885 (1) : 73 - 73
[5] ValproateSomnolence and lack of efficacy following off-label use: 5 case reports
[J]. Reactions Weekly, 2022, 1903 (1) : 362 - 362
[6] Dexamethasone/diltiazem/remdesivirBradycardia, cardiotoxicity, lack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1969 (1) : 146 - 146
[7] Azithromycin/hydroxychloroquineQTc prolongation following off-label use: 2 case reports
[J]. Reactions Weekly, 2021, 1842 (1) : 83 - 83
[8] Azithromycin/hydroxychloroquineCardiac arrest following off-label use: 2 case reports
[J]. Reactions Weekly, 2020, 1830 (1) : 74 - 74
[9] Azithromycin/dexamethasone/voriconazolePulmonary aspergillosis following off-label use, and lack of efficacy: case report
[J]. Reactions Weekly, 2021, 1848 (1) : 84 - 84
[10] Ceftriaxone/favipiravir/levofloxacinLack of efficacy followed by off-label use: 2 case reports
[J]. Reactions Weekly, 2023, 1945 (1) : 155 - 155

← 1 2 3 4 5 →